Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Moodys
McKesson
Federal Trade Commission
Mallinckrodt
QuintilesIMS
Cerilliant
Accenture
Medtronic

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 012394

« Back to Dashboard

NDA 012394 describes DISOPHROL, which is a drug marketed by Schering Plough and Schering and is included in two NDAs. Additional details are available on the DISOPHROL profile page.

The generic ingredient in DISOPHROL is dexbrompheniramine maleate; pseudoephedrine sulfate. There are seven drug master file entries for this compound. Additional details are available on the dexbrompheniramine maleate; pseudoephedrine sulfate profile page.
Summary for 012394
Tradename:DISOPHROL
Applicant:Schering
Ingredient:dexbrompheniramine maleate; pseudoephedrine sulfate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength2MG;60MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Moodys
Federal Trade Commission
Argus Health
Queensland Health
Fuji
Medtronic
Cerilliant
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.